Skip to main content
Equibles
COYA logo

COYA · Coya Therapeutics, Inc. · Metrics

Track COYA — free

Use COYA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research COYA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.21 +0.01 (+0.24%) At close · Oct 20
Rebalance outlook locked
Market Cap
$98.76M
Shares
23.46M
Volume · Oct 20 82.91K Avg daily vol (3M) 137.74K

COYA metrics

68 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.21
Market cap
$98.76M

Price action

20 metrics
Price change (1W)
-5.9%
Price change (30D)
-14.9%
Price change (3M)
-7.5%
Price change (6M)
-7.1%
Price change (YTD)
-27.4%
Price change (1Y)
-34.3%
Trailing year
Price change (5Y)
—
52-week high
$7.36
52-week low
$3.78
Change from 52-week high
-42.8%
Change from 52-week low
+11.4%
Annualized volatility
61.6%
Annualized volatility (3M)
53.5%
Beta
1.5
RSI (14D)
36.2
Price vs SMA 50
-11.2%
Price vs SMA 200
-10.1%
Avg volume (3M)
137,738
Relative volume
0.6
Average dollar volume
$639,354

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
23.46M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
12.3×
reciprocal yield 8.1%
P / book
2.3
reciprocal yield 43.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-21.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-06-02

Profitability

9 metrics
Gross margin
—
Operating margin
-288.7%
Trailing 12 months
Net margin
-270.2%
Gross profit (TTM)
—
Operating profit (TTM)
−$23.15M
Net income (TTM)
−$21.67M
Trailing 12 months
Diluted EPS (TTM)
$-1.07
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.47
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-1.14
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-1.07
Operating cash flow per diluted share (TTM)
$-0.72
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.86
Stock compensation per diluted share (TTM)
$0.27
Book value per share
$2.06

Growth

11 metrics
Revenue growth YoY
+49.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$8.02M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+40.3%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-50.1%
Return on assets
-45.8%
Debt / equity
—
Current ratio
13.4
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
13.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$43.18M
Latest balance sheet
Cash & equivalents
$43.18M
Total assets
$47.31M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$15.72M
Capital expenditures (TTM)
—
R&D (TTM)
$16.98M
SG&A (TTM)
—
Stock compensation (TTM)
$5.31M
R&D / revenue
211.8%
Stock compensation / revenue
66.3%

Ownership (13F)

9 metrics
13F filers
55
13F filer change QoQ
-2
Institutional ownership
33.4%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
21.3%
Private-fund adviser ownership
17.2%
Active holders' share change QoQ
-5.5%
Holder tenure
7.5
Price vs estimated holder cost
+4.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
4.7%

Short interest

3 metrics
Short interest
5.1%
Latest settlement · 7.0 days to cover
Days to cover
7.0d
Short-squeeze score
67 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1835022 CUSIP 22407B108 13F (30d) 3 filings 3 filers Visit website Investor relations